Jason Mills Recent News
Here's Every Sell-Side Rating Following iRhythm's IPO Quiet Period Expiration
Intuitive Surgical Shares Expected To Trade Significantly Higher, Says Canaccord
Canaccord Says The Nellix 'Carrot' Should Drive Endologix Higher
Intuitive Surgical Has 'Ample Runway' To Grow Despite Medtronic's Robotic Surgery Push, Canaccord Says
Novadaq 'Positioned For A Strong Run'; Canaccord Reiterates Buy
Canaccord Starts Penumbra At Buy, Sees 'Stroke Of Genius'
Canaccord Analysts Recommend 'Aggressively Buying' AtriCure After Sell-Off
Canaccord Upgrades Intuitive Surgical To Buy, Sees $615 Target On 'Robotic Renaissance'